Skip to main content
Clinical Trials/NCT01626742
NCT01626742
Completed
Phase 3

A Randomized Double Blinded Controlled Trial of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients

Abbott Nutrition118 sites in 1 country652 target enrollmentMay 2012

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Hospitalized Elderly
Sponsor
Abbott Nutrition
Enrollment
652
Locations
118
Primary Endpoint
Return to hospital or death
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Evaluate effects of an oral nutritional supplement on healthcare outcomes in older hospitalized adults. Also referred to as the NOURISH Study - Nutrition effect On Unplanned Readmissions and Survival in Hospitalized patients.

Registry
clinicaltrials.gov
Start Date
May 2012
End Date
October 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female ≥ 65 years of age.
  • Admitted to hospital with diagnosis of heart failure, acute myocardial infarction, pneumonia, or chronic obstructive pulmonary disease.
  • Subjective Global Assessment rating of B or C.
  • Length of hospital stay anticipated to be \> 3 days and \< 12 days
  • Able to consume foods and beverages orally.
  • Functionally ambulatory during the 30 days prior to admission.

Exclusion Criteria

  • Uncontrolled hypertension
  • Diagnosis of diabetes
  • Current active cancer or recently treated cancer
  • Impaired renal function
  • Liver failure, acute Hepatitis, or hepatic encephalopathy
  • Active tuberculosis.
  • Disorder of gastrointestinal tract
  • Autoimmune disorder
  • Intubation, and/or tube or parenteral feeding.
  • Severe dementia or delirium, brain metastases, eating disorder, history of significant neurological or psychiatric disorder, alcoholism, substance abuse or other conditions that may interfere with study product consumption or compliance with study protocol procedures

Outcomes

Primary Outcomes

Return to hospital or death

Time Frame: 90 days

Secondary Outcomes

  • Return to hospital or death(30 and 60 days)
  • Hospital Days(90 days)
  • Activities of Daily Living(90 days)

Study Sites (118)

Loading locations...

Similar Trials